Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ophthalmology
Sort By
Newest First
Sign in
1 / 1
1 / 1
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD, part of Thermo Fisher Scientific
PAO-08-24-CL-05
Sep 16, 2024
Retinal Disease
Pioneering Breakthroughs in Retinal Disease Treatment
David Alvaro, Ph.D.; David Zacks, M.D., Ph.D.; David Esposito
Pharma's Almanac
PAO-12-23-CL-01
Dec 14, 2023
Ophthalmic
Transformative Early and Patient-Centric Treatments for Retinal Diseases
David Alvaro, Ph.D.; Kerrie Brady
Pharma's Almanac
PAO-05-022-CL-06
May 17, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04
May 09, 2022
Ophthalmology
On the Future of Ocular Therapies
Roca Therapeutics
PAO-04-22-R221-63
Apr 29, 2021
Ophthalmology
Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction
Hovione
PR-M03-21-003
Mar 17, 2021
Ophthalmic Formulation
Targeting Retinal Diseases with an Ophthalmic Formulation of Bevacizumab
Larry Kenyon
Outlook Therapeutics
PAP-Q4-20-CL-018
Dec 09, 2020
Ophthalmology
Tackling Genetic Eye Diseases with Novel RNA Therapies
Daniel A. de Boer
ProQR Therapeutics
PAP-Q4-19-CL-027
Dec 06, 2019
Ophthalmology
Innovative Therapies to Treat Rare and Underserved Eye Diseases
Shankar Musunuri, Ph.D.
Ocugen
PAP-Q4-19-CL-025
Dec 06, 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics
PR-M01-19-NI-096
Feb 01, 2019
